Metformin Attenuates Vocal Fold Fibrosis via AMPK Signaling
Inflammation · 24.10.2024 · 48 (4) · 1929-1939
DOI: 10.1007/s10753-024-02165-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, online erschienen am 24.10.2024. Verfasst von Jie Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430000, China. Hauptthemen laut MEDLINE: Metformin, Vocal Cords, Signal Transduction, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Vocal fold fibrosis is a challenging condition with no clear consensus on effective treatment methods. Given the demonstrated efficacy of metformin in treating various fibrotic diseases, we hypothesized that metformin could reduce vocal fold fibrosis via the AMPK signaling pathway. In our study, we induced vocal fold injury in rabbits and administered metformin intraperitoneally at a dose of 250 mg/kg two weeks post-injury. Four weeks after the injury, vocal folds were excised and analyzed for fibrosis using Masson's trichrome staining, immunohistochemistry, quantitative real-time polymerase chain reaction (qPCR), and Western blotting. In vitro, vocal fold fibroblasts treated with metformin (10 μM) ± TGF-β1 (10 ng/mL) were utilized to assess metformin's antifibrotic effects, with Compound C (10 μM) employed to inhibit AMPK signaling. Our results demonstrate that metformin significantly improved the structural integrity of the vocal fold lamina, reduced collagen deposition, and decreased the expression levels of COL1A1 and α-SMA. Furthermore, metformin activated the AMPK signaling pathway in vocal fold fibroblasts, resulting in decreased expression of COL1A1, α-SMA, TGF-β, Smad2, and Smad3. These findings suggest that metformin attenuates vocal fold fibrosis by modulating the AMPK signaling pathway, providing a foundation for developing new therapeutic options for vocal fold fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430000, China.
- Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430000, China. zn_chenxiong@whu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cai, J., Fang, L., Zhou, P., Wu, J., Song, Y., Tuohuti, A., Sun, Y., & Chen, X. (2024). Metformin Attenuates Vocal Fold Fibrosis via AMPK Signaling. Inflammation, 48(4), 1929-1939. https://doi.org/10.1007/s10753-024-02165-5
Vancouver
Cai J, Fang L, Zhou P, Wu J, Song Y, Tuohuti A, et al. Metformin Attenuates Vocal Fold Fibrosis via AMPK Signaling. Inflammation. 2024;48(4):1929-1939. doi:10.1007/s10753-024-02165-5
BibTeX
@article{Cai2024,
author = {Cai, Jie and Fang, Lucheng and Zhou, Peng and Wu, Jianghao and Song, Yuliang and Tuohuti, Aikebaier and Sun, Yuechen and Chen, Xiong},
title = {Metformin Attenuates Vocal Fold Fibrosis via AMPK Signaling},
journal = {Inflammation},
year = {2024},
volume = {48},
number = {4},
pages = {1929--1939},
doi = {10.1007/s10753-024-02165-5}
}
EUVIMED